NL-OMON46285已完成4 期
Postprandial Lipemia, Inflammation, and Vascular Function in Diabetes modulated by dapagliflozin - PLEIADES-dapa
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age of 18 years of older
- •- Male sex
- •- Diabetes mellitus type II on intensive insulin treatment (three times short acting and once daily long acting)(unchanged for >10 weeks prior to inclusion
- •- Stable glucose regulation last 6 months (HbA1c >6.5% - <9%)
- •- Provision of informed consent prior to any study procedure
排除标准
- •- Current smoking
- •- Impaired renal function (MDRD <60 ml/min/1.73m2)
- •- Recent use of SGLT2 inhibitior (past 6 months)
- •- Recent cardiovascular event (past 6 months) (myocardial infarction, coronary artery bypass grafting, stroke)
- •- Severe hyperglycemic events in the past 6 months (hyperglycemie > 20mmol/l requiring hospital admission)
- •- Provision of informed consent prior to any study procedure
- •- Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
- •- Previous enrollment in the present study
- •- Participation in another clinical study with an investigational product during the last 6 months
研究者
相似试验
尚未招募
不适用
Postprandial effects of dapagliflozin on lipemia and inflammatioType 2 Diabetes MellitusNL-OMON21590Franciscus Gasthuis, Rotterdam20
进行中（未招募）
1 期
Influence of a new diabetesmedicine on cholesterol and other factors after intake of a fatty meal in patients with diabetesDiabetes Mellitus type IIEUCTR2016-001417-24-NLFranciscus Gasthuis
尚未招募
不适用
Postprandial vascular inflammation after high-fat meal in healthy subjectshealthy adultsJPRN-UMIN000022103Tokyo Medical and Dental University20
已完成
4 期
MODULATION OF POSTPRANDIAL LIPEMIA, INFLAMMATION, AND VASCULAR FUNCTION BY PCSK9 INHIBITION IN DIABETES.fat loadingPostprandial lipemia100184241001331710003216NL-OMON43374Sint Franciscus Gasthuis12
进行中（未招募）
1 期
Influence of a new medicine on cholesterol and other factors after intake of a meal in patients with diabetesDiabetes mellitus type 2EUCTR2016-003253-15-NLFranciscus Gasthui